In NSCLC, high frequencies of TLS containing mature DCs define a TME biased toward antitumor immunity, characterized by the upregulation of genes involved in both CD4+ and CD8+ T cell activation and cytotoxic function, and associated with improved patient survival [51]. Here, CD4 is linked to non-small cell lung carcinoma.